Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 (ECMO-COVID-19)

University Hospital, Strasbourg, France

Status: Completed

Conditions: Respiratory Distress Syndrome

Study type: Observational

Funder types: Other

Identifiers

NCT04343404

7772

Details and patient eligibility

About

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient over the age of 18;
• Diagnostic COVID-19 by RT-PCR;
• Hospitalisation in resuscitation for the management of complications related to COVID-19
• Implanted ECMO-VV during hospitalisation;
• Patient agreeing to participate in the study

Exclusion criteria

• Sujet under guardianship or trusteeship
• Sujet under safeguard of justice